EGFR and neoplasm: Additional findings from our laboratory also point to the lack of activating mutations in EGFR and ErbB3 genes, giving further strength to ligand-driven tumour cell proliferation as a paramount tumourigenic mechanism within the PDAC microenvironment (Tzeng et al, 2007a).